{"id":5469,"date":"2024-08-07T09:25:17","date_gmt":"2024-08-07T01:25:17","guid":{"rendered":"https:\/\/helixism.com\/?p=5469"},"modified":"2024-08-07T09:55:55","modified_gmt":"2024-08-07T01:55:55","slug":"hecp-1000-officially-receives-taiwan-fda","status":"publish","type":"post","link":"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/","title":{"rendered":"HECP-1000 Officially Receives Taiwan FDA"},"content":{"rendered":"<p>We are pleased to announce that our HECP-1000 device has successfully obtained approval from the Taiwan FDA this May, marking a significant milestone in the history of external counterpulsation (ECP) products.<\/p>\n<p>&nbsp;<\/p>\n<p>The Taiwan FDA approval is a recognition of the safety and efficacy of the HECP-1000 and reflects our commitment to providing advanced solutions that enhance health and well-being.<\/p>\n<p>&nbsp;<\/p>\n<p>We are excited to introduce the HECP-1000 to the public in Taiwan and look forward to continuing our innovation in the medical device field.<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-5694\" src=\"https:\/\/helixism.com\/wp-content\/uploads\/2024\/08\/S__20922375_0.jpg\" alt=\"\" width=\"1030\" height=\"801\" srcset=\"https:\/\/helixism.com\/wp-content\/uploads\/2024\/08\/S__20922375_0.jpg 1030w, https:\/\/helixism.com\/wp-content\/uploads\/2024\/08\/S__20922375_0-257x200.jpg 257w, https:\/\/helixism.com\/wp-content\/uploads\/2024\/08\/S__20922375_0-768x597.jpg 768w, https:\/\/helixism.com\/wp-content\/uploads\/2024\/08\/S__20922375_0-705x548.jpg 705w\" sizes=\"(max-width: 1030px) 100vw, 1030px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>We are pleased to announce that our HECP-1000 device has successfully obtained approval from the Taiwan FDA this May, marking a significant milestone in the history of external counterpulsation (ECP) products. &nbsp; The Taiwan FDA approval is a recognition of the safety and efficacy of the HECP-1000 and reflects our commitment to providing advanced solutions [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":5700,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.13 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>HECP-1000 Officially Receives Taiwan FDA - \u79be\u65b0\u751f\u91ab\u80a1\u4efd\u6709\u9650\u516c\u53f8 Helixism Biomedical Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HECP-1000 Officially Receives Taiwan FDA - \u79be\u65b0\u751f\u91ab\u80a1\u4efd\u6709\u9650\u516c\u53f8 Helixism Biomedical Inc.\" \/>\n<meta property=\"og:description\" content=\"We are pleased to announce that our HECP-1000 device has successfully obtained approval from the Taiwan FDA this May, marking a significant milestone in the history of external counterpulsation (ECP) products. &nbsp; The Taiwan FDA approval is a recognition of the safety and efficacy of the HECP-1000 and reflects our commitment to providing advanced solutions [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"\u79be\u65b0\u751f\u91ab\u80a1\u4efd\u6709\u9650\u516c\u53f8 Helixism Biomedical Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-07T01:25:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-07T01:55:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/helixism.com\/wp-content\/uploads\/2024\/08\/S__20922375_642px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"642\" \/>\n\t<meta property=\"og:image:height\" content=\"641\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"info.tw\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info.tw\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/\",\"url\":\"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/\",\"name\":\"HECP-1000 Officially Receives Taiwan FDA - \u79be\u65b0\u751f\u91ab\u80a1\u4efd\u6709\u9650\u516c\u53f8 Helixism Biomedical Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/helixism.com\/#website\"},\"datePublished\":\"2024-08-07T01:25:17+00:00\",\"dateModified\":\"2024-08-07T01:55:55+00:00\",\"author\":{\"@id\":\"https:\/\/helixism.com\/#\/schema\/person\/3a517a8a6bdcef215ccb153f629cfff1\"},\"breadcrumb\":{\"@id\":\"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\/\/helixism.com\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HECP-1000 Officially Receives Taiwan FDA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/helixism.com\/#website\",\"url\":\"https:\/\/helixism.com\/\",\"name\":\"\u79be\u65b0\u751f\u91ab\u80a1\u4efd\u6709\u9650\u516c\u53f8 Helixism Biomedical Inc.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/helixism.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/helixism.com\/#\/schema\/person\/3a517a8a6bdcef215ccb153f629cfff1\",\"name\":\"info.tw\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/helixism.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c10f50a552074bf48d7b9bf057c6b0ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c10f50a552074bf48d7b9bf057c6b0ce?s=96&d=mm&r=g\",\"caption\":\"info.tw\"},\"url\":\"https:\/\/helixism.com\/en\/author\/info-tw\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HECP-1000 Officially Receives Taiwan FDA - \u79be\u65b0\u751f\u91ab\u80a1\u4efd\u6709\u9650\u516c\u53f8 Helixism Biomedical Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/","og_locale":"en_US","og_type":"article","og_title":"HECP-1000 Officially Receives Taiwan FDA - \u79be\u65b0\u751f\u91ab\u80a1\u4efd\u6709\u9650\u516c\u53f8 Helixism Biomedical Inc.","og_description":"We are pleased to announce that our HECP-1000 device has successfully obtained approval from the Taiwan FDA this May, marking a significant milestone in the history of external counterpulsation (ECP) products. &nbsp; The Taiwan FDA approval is a recognition of the safety and efficacy of the HECP-1000 and reflects our commitment to providing advanced solutions [&hellip;]","og_url":"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/","og_site_name":"\u79be\u65b0\u751f\u91ab\u80a1\u4efd\u6709\u9650\u516c\u53f8 Helixism Biomedical Inc.","article_published_time":"2024-08-07T01:25:17+00:00","article_modified_time":"2024-08-07T01:55:55+00:00","og_image":[{"width":642,"height":641,"url":"https:\/\/helixism.com\/wp-content\/uploads\/2024\/08\/S__20922375_642px.jpg","type":"image\/jpeg"}],"author":"info.tw","twitter_card":"summary_large_image","twitter_misc":{"Written by":"info.tw","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/","url":"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/","name":"HECP-1000 Officially Receives Taiwan FDA - \u79be\u65b0\u751f\u91ab\u80a1\u4efd\u6709\u9650\u516c\u53f8 Helixism Biomedical Inc.","isPartOf":{"@id":"https:\/\/helixism.com\/#website"},"datePublished":"2024-08-07T01:25:17+00:00","dateModified":"2024-08-07T01:55:55+00:00","author":{"@id":"https:\/\/helixism.com\/#\/schema\/person\/3a517a8a6bdcef215ccb153f629cfff1"},"breadcrumb":{"@id":"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/helixism.com\/en\/hecp-1000-officially-receives-taiwan-fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/helixism.com\/en\/home\/"},{"@type":"ListItem","position":2,"name":"HECP-1000 Officially Receives Taiwan FDA"}]},{"@type":"WebSite","@id":"https:\/\/helixism.com\/#website","url":"https:\/\/helixism.com\/","name":"\u79be\u65b0\u751f\u91ab\u80a1\u4efd\u6709\u9650\u516c\u53f8 Helixism Biomedical Inc.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helixism.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/helixism.com\/#\/schema\/person\/3a517a8a6bdcef215ccb153f629cfff1","name":"info.tw","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/helixism.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c10f50a552074bf48d7b9bf057c6b0ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c10f50a552074bf48d7b9bf057c6b0ce?s=96&d=mm&r=g","caption":"info.tw"},"url":"https:\/\/helixism.com\/en\/author\/info-tw\/"}]}},"_links":{"self":[{"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/posts\/5469"}],"collection":[{"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/comments?post=5469"}],"version-history":[{"count":4,"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/posts\/5469\/revisions"}],"predecessor-version":[{"id":5698,"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/posts\/5469\/revisions\/5698"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/media\/5700"}],"wp:attachment":[{"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/media?parent=5469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/categories?post=5469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helixism.com\/en\/wp-json\/wp\/v2\/tags?post=5469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}